AMPH|Amphastar Pharmaceuticals Inc|Preço:29.260|Var. %:0.63

Mais detalhes de Amphastar Pharmaceuticals Inc Empresa

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Informações de Amphastar Pharmaceuticals Inc



Código da empresaAMPH

Nome da EmpresaAmphastar Pharmaceuticals Inc

Data de listagemJun 25, 2014

CEOZhang (Yongfeng Yongfeng)

Número de funcionários2028

Tipo de títulosOrdinary Share

Fim do ano fiscalJun 25

Endereço11570 6th St

CidadeRANCHO CUCAMONGA

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal91730

Telefone19099809484

Sitehttps://amphastar.com/

Código da empresaAMPH

Data de listagemJun 25, 2014

CEOZhang (Yongfeng Yongfeng)

Executivos da empresa Amphastar Pharmaceuticals Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Rong Zhou

Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.

197.10K

--

Dr. Howard S. Lee, Ph.D.

Independent Director

148.90K

+4199.00%

Mr. Floyd F. Petersen

Independent Director

68.29K

-4163.00%

Mr. William J. Peters

Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director

55.44K

-273.00%

Mr. Richard K. Prins

Lead Independent Director

32.11K

--

Ms. Gayle Deflin

Independent Director

7.84K

+5122.00%

Dr. Yongfeng (Jack) Zhang, Ph.D.

President, Chief Executive Officer, Chief Scientific Officer, Director

--

Dr. Ziping (Mary) Luo, Ph.D.

Chairman of the Board, Chief Operating Officer, Chief Scientist

--

Ms. Diane G. Gerst

Independent Director

--

Dr. Michael A. Zasloff, M.D., Ph.D.

Independent Director

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Rong Zhou

Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.

197.10K

--

Dr. Howard S. Lee, Ph.D.

Independent Director

148.90K

+4199.00%

Mr. Floyd F. Petersen

Independent Director

68.29K

-4163.00%

Mr. William J. Peters

Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director

55.44K

-273.00%

Mr. Richard K. Prins

Lead Independent Director

32.11K

--

Ms. Gayle Deflin

Independent Director

7.84K

+5122.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Os dados relevantes ainda não foram divulgados pela empresa.

Por RegiãoUSD

Nome

Receita

Proporção

United States

180.28M

93.97%

France

9.68M

5.05%

China

1.88M

0.98%

Por Empresa

Por Região

Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 16 de nov

Investidores

Tipos de investidores

Investidores

Proporção

Applied Physics & Chemistry Laboratories, Inc.

14.86%

BlackRock Institutional Trust Company, N.A.

10.75%

Zhang (Jack Yongfeng)

5.71%

The Vanguard Group, Inc.

5.63%

TD Asset Management Inc.

4.20%

Outro

58.85%

Investidores

Proporção

Applied Physics & Chemistry Laboratories, Inc.

14.86%

BlackRock Institutional Trust Company, N.A.

10.75%

Zhang (Jack Yongfeng)

5.71%

The Vanguard Group, Inc.

5.63%

TD Asset Management Inc.

4.20%

Outro

58.85%

Tipos de investidores

Investidores

Proporção

Investment Advisor

40.25%

Investment Advisor/Hedge Fund

22.89%

Corporation

14.86%

Individual Investor

9.43%

Hedge Fund

6.46%

Research Firm

2.82%

Pension Fund

1.05%

Bank and Trust

0.31%

Family Office

0.28%

Outro

1.65%

Participação acionária institucional



Atualizado em: seg, 8 de dez

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

586

33.97M

85.20%

+16.67K

2025Q3

603

33.96M

84.80%

+202.84K

2025Q2

607

33.74M

83.87%

-544.61K

2025Q1

597

34.53M

80.40%

-3.80M

2024Q4

593

35.69M

79.40%

-112.11K

2024Q3

575

35.68M

75.48%

+965.70K

2024Q2

565

34.64M

73.86%

+833.26K

2024Q1

548

33.97M

73.49%

-1.92M

2023Q4

531

33.91M

72.12%

+1.03M

2023Q3

499

32.97M

71.03%

+509.94K

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Applied Physics & Chemistry Laboratories, Inc.

6.83M

14.86%

--

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.94M

10.75%

-185.58K

-3.62%

Sep 30, 2025

Zhang (Jack Yongfeng)

2.62M

5.71%

+200.00K

+8.25%

Jun 13, 2025

The Vanguard Group, Inc.

2.61M

5.68%

-55.91K

-2.10%

Sep 30, 2025

TD Asset Management Inc.

1.93M

4.2%

-103.04K

-5.06%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.76M

3.82%

+128.78K

+7.92%

Sep 30, 2025

State Street Investment Management (US)

1.50M

3.27%

-75.49K

-4.79%

Sep 30, 2025

Fuller & Thaler Asset Management Inc.

1.35M

2.95%

+90.16K

+7.13%

Sep 30, 2025

Epoch Investment Partners, Inc.

1.13M

2.47%

-107.38K

-8.65%

Sep 30, 2025

Luo (Mary Z)

1.09M

2.37%

+69.40K

+6.79%

Mar 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

Invesco Pharmaceuticals ETF

2.25%

State Street SPDR S&P Pharmaceuticals ETF

1.47%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.38%

Invesco S&P SmallCap 600 GARP ETF

1.12%

Acquirers Small and Micro Deep Value ETF

0.87%

Pacer US Small Cap Cash Cows Growth Leaders ETF

0.77%

Invesco S&P SmallCap Health Care ETF

0.56%

First Trust Small Cap Value AlphaDEX Fund

0.5%

Distillate Small/Mid Cash Flow ETF

0.45%

VictoryShares Small Cap Free Cash Flow ETF

0.37%

Ver Mais

Invesco Pharmaceuticals ETF

Proporção2.25%

State Street SPDR S&P Pharmaceuticals ETF

Proporção1.47%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

Proporção1.38%

Invesco S&P SmallCap 600 GARP ETF

Proporção1.12%

Acquirers Small and Micro Deep Value ETF

Proporção0.87%

Pacer US Small Cap Cash Cows Growth Leaders ETF

Proporção0.77%

Invesco S&P SmallCap Health Care ETF

Proporção0.56%

First Trust Small Cap Value AlphaDEX Fund

Proporção0.5%

Distillate Small/Mid Cash Flow ETF

Proporção0.45%

VictoryShares Small Cap Free Cash Flow ETF

Proporção0.37%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados